Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2021 and Provides Business Update

NEXT STORY
iBio to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Update on Tuesday, February 16, 2021
PREV STORY
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Rexahn Pharmaceuticals Reports First Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Clarus Therapeutics Announces Commercial Launch and Availability of JATENZO® (testosterone undecanoate) capsules, CIII for the Treatment of Hypogonadism

author_avatar
NASDAQ Market News

Onconova Therapeutics Announces License Agreement with Pint Pharma to Commercialize Rigosertib for Treatment of Myelodysplastic Syndromes in Latin America

• Pint Pharma to Make Upfront Investment in Onconova• Onconova also Eligible to Receive ...

author_avatar
NASDAQ Market News